Viewing StudyNCT00418574



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00418574
Status: TERMINATED
Last Update Posted: 2011-11-24
First Post: 2007-01-04

Brief Title: Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Sponsor: Menarini Group
Organization: Menarini Group

Conditions & Keywords Data

Conditions:
Name
Ovarian Cancer
Keywords:
Name View
Abagovomab View
Ovarian cancer View